TY - CHAP AU - A.L. Corona-Nakamura AU - M.J. Arias-Merino ED - Patricia Price ED - Nandini Makwana ED - Samantha Brunt Y1 - 2013-05-29 PY - 2013 T1 - Management of CMV-Associated Diseases in Immunocompromised Patients N2 - Cytomegalovirus (CMV) is carried by 50 100% of the worlds population throughout their lives. Consequences are most readily seen in immunocompromised individuals such as organ transplant recipients, HIV-infected patients and new born infants. This book gives an in-depth view of manifestations of CMV infection in immunocompromised individuals: how it affects the immune system and how it is diagnosed and treated. The book also sheds light on the epidemiology and impact of CMV in sub-Saharan Africa, and also associations with age related disease that are more commonly seen in the western world. It particularly details a recent discovery between CMV and tumour immuno-biology. The book explores the development of a few compounds and also highlights the need to discover novel antiviral agents in future. BT - Manifestations of Cytomegalovirus Infection SP - Ch. 3 UR - https://doi.org/10.5772/56141 DO - 10.5772/56141 SN - PB - IntechOpen CY - Rijeka Y2 - 2024-03-28 ER -